US Stock MarketDetailed Quotes

Evofem Biosciences (EVFM)

Watchlist
  • 0.0074
  • -0.0003-3.29%
15min DelayClose May 13 15:18 ET
974.10KMarket Cap-0.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Evofem Biosciences (EVFM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
48.73%-1.99M
101.29%31K
173.20%336K
-155.83%-2.92M
355.28%560K
56.68%-3.89M
-1,316.47%-2.41M
80.58%-459K
23.63%-1.14M
102.49%123K
Net income from continuing operations
104.41%391K
191.80%2.79M
33.66%-1.57M
-232.05%-1.78M
119.88%956K
-116.72%-8.86M
-43.66%-3.04M
-103.58%-2.37M
115.79%1.35M
-104.29%-4.81M
Operating gains losses
-99.35%20K
--0
--0
-90.32%3K
-99.21%17K
104.49%3.06M
1,438.30%723K
100.20%143K
-98.36%31K
2,471.43%2.16M
Depreciation and amortization
-17.20%626K
-70.36%107K
-59.86%118K
221.43%135K
350.85%266K
-57.55%756K
438.81%361K
-77.31%294K
112.69%42K
-92.12%59K
Other non cash items
-267.01%-5.15M
8.25%617K
-196.08%-1.35M
7.89%588K
-987.41%-5.01M
70.90%3.08M
0.35%570K
317.00%1.4M
-58.65%545K
-0.18%564K
Change In working capital
-32.76%583K
-70.82%-4.23M
100.95%1.27M
-43,850.00%-1.76M
95.25%5.3M
-81.66%867K
-157.74%-2.47M
201.94%631K
-100.10%-4K
197.31%2.71M
-Change in receivables
35.32%-2.65M
-81.23%-8.05M
164.30%499K
-1,117.04%-3.79M
506.35%8.68M
11.23%-4.09M
-860.10%-4.44M
30.96%-776K
-114.10%-311K
122.81%1.43M
-Change in inventory
-556.14%-260K
114.12%25K
155.09%222K
45.12%357K
-320.97%-864K
-97.29%57K
-123.35%-177K
-12.89%-403K
-86.36%246K
494.95%391K
-Change in prepaid assets
234.34%356K
68.70%-144K
374.68%423K
86.61%-30K
-81.33%107K
-107.24%-265K
-206.98%-460K
-119.35%-154K
-124.43%-224K
-62.25%573K
-Change in payables and accrued expense
-29.04%3.74M
50.70%3.98M
-89.45%206K
572.19%2.15M
-811.81%-2.59M
4.43%5.28M
3.13%2.64M
1,674.55%1.95M
214.70%320K
-86.32%364K
-Change in other current liabilities
-473.58%-608K
-5.41%-39K
-783.33%-82K
-1,188.57%-451K
21.74%-36K
92.83%-106K
19.57%-37K
127.27%12K
95.61%-35K
92.22%-46K
Cash from discontinued investing activities
Operating cash flow
48.73%-1.99M
101.29%31K
173.20%336K
-155.83%-2.92M
355.28%560K
56.68%-3.89M
-1,316.47%-2.41M
80.58%-459K
23.63%-1.14M
102.49%123K
Investing cash flow
Cash flow from continuing investing activities
89.10%-62K
93.48%-3K
0
-2K
-307.14%-57K
-14,125.00%-569K
-46K
-509K
0
-366.67%-14K
Net PPE purchase and sale
64.29%-5K
---3K
--0
---2K
--0
-250.00%-14K
--0
--0
--0
-366.67%-14K
Net other investing changes
89.73%-57K
--0
--0
--0
---57K
---555K
---46K
----
----
----
Cash from discontinued investing activities
Investing cash flow
89.10%-62K
93.48%-3K
--0
---2K
-307.14%-57K
-14,125.00%-569K
---46K
---509K
--0
-366.67%-14K
Financing cash flow
Cash flow from continuing financing activities
-59.02%1.89M
-111.73%-290K
-124.45%-244K
123.78%2.56M
-135K
-3.37%4.62M
627.35%2.47M
-53.32%998K
91.62%1.14M
0
Net issuance payments of debt
594.29%1.9M
-4.12%-278K
6.87%-244K
1,677.78%2.56M
---135K
-108.58%-385K
-219.20%-267K
-112.34%-262K
-71.08%144K
--0
Net common stock issuance
--0
----
----
----
----
--5M
----
----
----
----
Proceeds from stock option exercised by employees
----
----
----
----
----
--0
--0
--0
--0
--0
Net other financing activities
---12K
----
----
----
----
----
----
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-59.02%1.89M
-111.73%-290K
-124.45%-244K
123.78%2.56M
---135K
-3.37%4.62M
627.35%2.47M
-53.32%998K
91.62%1.14M
--0
Net cash flow
Beginning cash position
27.76%741K
16.34%840K
8.09%748K
60.96%1.11M
27.76%741K
-87.86%580K
76.10%722K
8.81%692K
-55.08%689K
-87.86%580K
Current changes in cash
-201.24%-163K
-1,478.95%-262K
206.67%92K
-12,133.33%-361K
237.61%368K
103.84%161K
-88.82%19K
113.27%30K
100.33%3K
103.36%109K
End cash Position
-22.00%578K
-22.00%578K
16.34%840K
8.09%748K
60.96%1.11M
27.76%741K
27.76%741K
76.10%722K
8.81%692K
-55.08%689K
Free cash flow
48.78%-2M
101.16%28K
173.20%336K
-156.00%-2.92M
413.76%560K
56.54%-3.9M
-1,316.47%-2.41M
80.58%-459K
23.68%-1.14M
102.21%109K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 48.73%-1.99M101.29%31K173.20%336K-155.83%-2.92M355.28%560K56.68%-3.89M-1,316.47%-2.41M80.58%-459K23.63%-1.14M102.49%123K
Net income from continuing operations 104.41%391K191.80%2.79M33.66%-1.57M-232.05%-1.78M119.88%956K-116.72%-8.86M-43.66%-3.04M-103.58%-2.37M115.79%1.35M-104.29%-4.81M
Operating gains losses -99.35%20K--0--0-90.32%3K-99.21%17K104.49%3.06M1,438.30%723K100.20%143K-98.36%31K2,471.43%2.16M
Depreciation and amortization -17.20%626K-70.36%107K-59.86%118K221.43%135K350.85%266K-57.55%756K438.81%361K-77.31%294K112.69%42K-92.12%59K
Other non cash items -267.01%-5.15M8.25%617K-196.08%-1.35M7.89%588K-987.41%-5.01M70.90%3.08M0.35%570K317.00%1.4M-58.65%545K-0.18%564K
Change In working capital -32.76%583K-70.82%-4.23M100.95%1.27M-43,850.00%-1.76M95.25%5.3M-81.66%867K-157.74%-2.47M201.94%631K-100.10%-4K197.31%2.71M
-Change in receivables 35.32%-2.65M-81.23%-8.05M164.30%499K-1,117.04%-3.79M506.35%8.68M11.23%-4.09M-860.10%-4.44M30.96%-776K-114.10%-311K122.81%1.43M
-Change in inventory -556.14%-260K114.12%25K155.09%222K45.12%357K-320.97%-864K-97.29%57K-123.35%-177K-12.89%-403K-86.36%246K494.95%391K
-Change in prepaid assets 234.34%356K68.70%-144K374.68%423K86.61%-30K-81.33%107K-107.24%-265K-206.98%-460K-119.35%-154K-124.43%-224K-62.25%573K
-Change in payables and accrued expense -29.04%3.74M50.70%3.98M-89.45%206K572.19%2.15M-811.81%-2.59M4.43%5.28M3.13%2.64M1,674.55%1.95M214.70%320K-86.32%364K
-Change in other current liabilities -473.58%-608K-5.41%-39K-783.33%-82K-1,188.57%-451K21.74%-36K92.83%-106K19.57%-37K127.27%12K95.61%-35K92.22%-46K
Cash from discontinued investing activities
Operating cash flow 48.73%-1.99M101.29%31K173.20%336K-155.83%-2.92M355.28%560K56.68%-3.89M-1,316.47%-2.41M80.58%-459K23.63%-1.14M102.49%123K
Investing cash flow
Cash flow from continuing investing activities 89.10%-62K93.48%-3K0-2K-307.14%-57K-14,125.00%-569K-46K-509K0-366.67%-14K
Net PPE purchase and sale 64.29%-5K---3K--0---2K--0-250.00%-14K--0--0--0-366.67%-14K
Net other investing changes 89.73%-57K--0--0--0---57K---555K---46K------------
Cash from discontinued investing activities
Investing cash flow 89.10%-62K93.48%-3K--0---2K-307.14%-57K-14,125.00%-569K---46K---509K--0-366.67%-14K
Financing cash flow
Cash flow from continuing financing activities -59.02%1.89M-111.73%-290K-124.45%-244K123.78%2.56M-135K-3.37%4.62M627.35%2.47M-53.32%998K91.62%1.14M0
Net issuance payments of debt 594.29%1.9M-4.12%-278K6.87%-244K1,677.78%2.56M---135K-108.58%-385K-219.20%-267K-112.34%-262K-71.08%144K--0
Net common stock issuance --0------------------5M----------------
Proceeds from stock option exercised by employees ----------------------0--0--0--0--0
Net other financing activities ---12K--------------------------0--------
Cash from discontinued financing activities
Financing cash flow -59.02%1.89M-111.73%-290K-124.45%-244K123.78%2.56M---135K-3.37%4.62M627.35%2.47M-53.32%998K91.62%1.14M--0
Net cash flow
Beginning cash position 27.76%741K16.34%840K8.09%748K60.96%1.11M27.76%741K-87.86%580K76.10%722K8.81%692K-55.08%689K-87.86%580K
Current changes in cash -201.24%-163K-1,478.95%-262K206.67%92K-12,133.33%-361K237.61%368K103.84%161K-88.82%19K113.27%30K100.33%3K103.36%109K
End cash Position -22.00%578K-22.00%578K16.34%840K8.09%748K60.96%1.11M27.76%741K27.76%741K76.10%722K8.81%692K-55.08%689K
Free cash flow 48.78%-2M101.16%28K173.20%336K-156.00%-2.92M413.76%560K56.54%-3.9M-1,316.47%-2.41M80.58%-459K23.68%-1.14M102.21%109K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -